Genocea Biosciences (GNCA) Misses Q3 EPS by 2c

Genocea Biosciences (NASDAQ: GNCA) reported Q3 EPS of ($0.53), $0.02 worse than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Deere (DE) PT Lowered to $570 at JPMorgan Ahead of Earnings